Pathophysiological Consequences of a Break in S1P1-Dependent Homeostasis of Vascular Permeability Revealed by S1P1 Competitive Antagonism.

Autor: Bigaud M; Novartis Institutes for Biomedical Research, Autoimmunity, Transplantation and Inflammation, Basel, Switzerland., Dincer Z; Novartis Institutes for Biomedical Research, Autoimmunity, Transplantation and Inflammation, Basel, Switzerland., Bollbuck B; Novartis Institutes for Biomedical Research, Autoimmunity, Transplantation and Inflammation, Basel, Switzerland., Dawson J; Novartis Institutes for Biomedical Research, Autoimmunity, Transplantation and Inflammation, Basel, Switzerland., Beckmann N; Novartis Institutes for Biomedical Research, Autoimmunity, Transplantation and Inflammation, Basel, Switzerland., Beerli C; Novartis Institutes for Biomedical Research, Autoimmunity, Transplantation and Inflammation, Basel, Switzerland., Fishli-Cavelti G; Novartis Institutes for Biomedical Research, Autoimmunity, Transplantation and Inflammation, Basel, Switzerland., Nahler M; Novartis Institutes for Biomedical Research, Autoimmunity, Transplantation and Inflammation, Basel, Switzerland., Angst D; Novartis Institutes for Biomedical Research, Autoimmunity, Transplantation and Inflammation, Basel, Switzerland., Janser P; Novartis Institutes for Biomedical Research, Autoimmunity, Transplantation and Inflammation, Basel, Switzerland., Otto H; Novartis Institutes for Biomedical Research, Autoimmunity, Transplantation and Inflammation, Basel, Switzerland., Rosner E; Novartis Institutes for Biomedical Research, Autoimmunity, Transplantation and Inflammation, Basel, Switzerland., Hersperger R; Novartis Institutes for Biomedical Research, Autoimmunity, Transplantation and Inflammation, Basel, Switzerland., Bruns C; Novartis Institutes for Biomedical Research, Autoimmunity, Transplantation and Inflammation, Basel, Switzerland., Quancard J; Novartis Institutes for Biomedical Research, Autoimmunity, Transplantation and Inflammation, Basel, Switzerland.

Publikováno v: PloS one [PLoS One] 2016 Dec 22; Vol. 11 (12), pp. e0168252. Date of Electronic Publication: 2016 Dec 22 (Print Publication: 2016).

Intensification of the CHOEP Regimen for High-Grade Non- Hodgkin's Lymphoma by G-CSF: Feasibility of a 14-Day Regimen.

Autor: Trümper, L., Renner, Ch., Nahler, M., Engert, A., Koch, P., Diehl, V, Pfreundschuh, M.

Publikováno v: Onkologie; 1994, Vol. 17 Issue 1, p69-71, 3p

New aspects in the treatment of advanced low-grade non-Hodgkin's lymphomas: prednimustine/mitoxantrone versus cyclophosphamide/vincristine/prednisone followed by interferon alfa versus observation only--a preliminary update of the German Low-Grade Lymphoma Study Group.

Autor: Hiddemann W; Department of Hematology and Oncology, University of Göttingen, Germany., Unterhalt M, Koch P, Nahler M, Herrmann R

Publikováno v: Seminars in hematology [Semin Hematol] 1994 Apr; Vol. 31 (2 Suppl 3), pp. 32-5.

alpha Interferon maintenance therapy in patients with low-grade non-Hodgkin's lymphomas after cytoreductive chemotherapy with prednimustine and mitoxantrone.

Autor: Hiddemann W; University of Münster, Department of Hematology/Oncology, Germany., Unterhalt M, Koch P, Nahler M, Herrmann R, van de Loo J

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 1991; Vol. 27 Suppl 4, pp. S37-9.

Clustering, collision, and relaxation dynamics in pure and doped helium nanoclusters: Density- vs particle-based approaches.

Autor: García-Alfonso, Ernesto, Barranco, Manuel, Bonhommeau, David A., Halberstadt, Nadine, Pi, Martí, Calvo, Florent

Publikováno v: Journal of Chemical Physics; 7/7/2022, Vol. 157 Issue 1, p1-14, 14p